The Future of Obesity Drugs

Eli Lilly CEO David Barger says the company is open to all ideas on how to pay for obesity drugs. We need Medicaid to pay for these drugs, and that may require more of a population health idea,. He also mentioned reinvesting in the company's obesity portfolio but also in other treatments such as Alzheimer's treatment.